1,893
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy

, , , , &
Pages 122-130 | Received 12 Sep 2019, Accepted 29 Nov 2019, Published online: 20 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Liam Spannenburg & Hayley Reed. (2023) Adverse cognitive effects of glucocorticoids: A systematic review of the literature. Steroids 200, pages 109314.
Crossref
Miao Liu, Di Huang, Enyu Liang, Bishun Deng, Huijie Huang, Zilin Zhao, Li Deng, Xiaowan Wang, Haibiao Lin, Kun Bao, Peng Xu & Min He. (2023) Elevated plasma interleukin 21 is associated with higher probability and severity of idiopathic membranous nephropathy. Journal of Laboratory Medicine 47:3, pages 121-127.
Crossref
Shunlai Shang, Shaoyuan Cui, Wenjuan Wang, Chao Wang, Ping Li, Wenge Li & Qinggang Li. (2022) Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy. Frontiers in Endocrinology 13.
Crossref
Jiarong Liu, Xiang Li, Tianlun Huang & Gaosi Xu. (2022) Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis. Frontiers in Pharmacology 13.
Crossref
Guoqun Zhou & Xiangdong Kong. (2021) Study on the Effect of Combination of Prednisone and Vitamin D in the Treatment of Primary Nephrotic Syndrome in Children. Journal of Healthcare Engineering 2021, pages 1-9.
Crossref
Lan Huang, Ya-Juan Zhao, Qiao-Rong Dong & Gui-Cai Hu. (2021) A study of altered calcium sensing system caused primary membranous nephropathy to end-stage renal failure. Biomedicine & Pharmacotherapy 141, pages 111777.
Crossref